Topics

Articles

The clock is ticking on a massive effort to bring interoperable, electronic tracking of pharma shipments in the US

Countdown to 2023 DSCSA Compliance

A recommended checklist for manufacturers as they enlist distributor and 3PL support—and the important questions they should be asking themselves  

The Key Steps Ahead of DSCSA D-Day

Pressure is mounting ahead of looming unit-level serialization required by the Drug Supply Chain Security Act—necessitating a wide scope of collaboration on compliance

New Serialization Mandates Inch Closer

Outlining the work of the Open Credentialing Initiative in establishing digital proof of identity, licensure status, and authorship using digital wallets and verifiable credentials

Closing a Key Gap in DSCSA Compliance

Tracy Nasarenko is Senior Director Community Engagement at 

From November 2023, the Drug Supply Chain Security Act requires healthcare manufacturers, distributors, providers, and dispensers to exchange the serialized item-level product information that has been collected, standardized, and digitized. Hitting this deadline hinges on intensive collaboration between manufacturers and their supply chain partners that must begin now

Flipping the Switch on DSCSA Interoperability

FROM PRMA CONSULTING

More biologic-based therapies translates into more cold chain activity. As yet, new cellular and genetic therapies are a minute part of the overall market.

Biopharma cold-chain market forecast

A 2017 postponement makes 2018 the key year for serializing US products; authentication makes a comeback, and cargo security goes digital

Pharma traceability lumbers along

Patient support (hub) services rise in lockstep with specialty pharmaceutical launches

The Hub Services Wheel keeps Rolling Along

Drug-based therapies for opioid dependency gain acceptance and reimbursement